The new 26,000 sq. ft. space expands the capacity of CoreRx’s oral and topical dosage form development group, increasing drug product volume through several formulation technologies that include: blending, roller compaction, wet granulation, fluid bed drying, spray drying, and extrusion spheronization. According to the company, the increased R&D development capacity is in response to higher demand for expert contract services. This expansion will assist its pharmaceutical chemists in the development of robust, reliable dosage form options made available to our clients.
This expansion gives CoreRx’s clients access to over 150,000 sq. ft. of space at the ICOT center campus.
The new facility is designed to streamline workflow and optimize product development efficiency, with analytical development, pre-formulation, and formulation development teams all collocated for optimal synergy.
“The establishment of our International Center of Excellence on our Clearwater campus is both an indicator of our continued growth and a commitment to our global and domestic customers,” said Bill Reid, chief operating officer, CoreRx. “Investing in new facilities, increasing development capacity, and expanding our capabilities help us to meet the growing demand for our services and is also an important way of creating jobs and supporting the communities where we operate.”